Abstract

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels

Author(s): Allen Loyd V Jr, Okeke Claudia C

Issue: Sep/Oct 2007 - Veterinary Compounding

Page(s): 404-410

Download in electronic PDF format for $75
  • Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Page 1
  • Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Page 2
  • Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Page 3
  • Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Page 4
  • Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Page 5
  • Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Page 6
  • Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Page 7

Abstract

The intent of United States Pharmacopeia Chapter <797> Pharmaceutical Compounding—Sterile Preparations is to prevent patient harm and fatalities that may result from nonsterility, excessive endotoxin load, large content errors in strength of correct ingredients, or the presence of incorrect ingredients. Understanding the different microbial contamination risk levels involved in compounding sterile preparations, how to appropriately assign those risk levels, and the steps needed to maintain sterility decreases the probability of a contaminated preparation.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2007
Pg. 404-410
Mar/Apr 2020
Pg. 92
Author(s): Allen Loyd V Jr
May/Jun 2008
Pg. 252-257
May/Jun 2020
Pg. 180
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Author(s): Allen Loyd V Jr
Mar/Apr 2008
Pg. 136-144
Jul/Aug 2007
Pg. 302-305
Author(s): Okeke Claudia C
May/Jun 2008
Pg. 216-229
Author(s): Kastango Eric S
Mar/Apr 2021
Pg. 115-124
Author(s): Kelley Brian
Sep/Oct 2008
Pg. 440-443
Jul/Aug 2013
Pg. 283-288
Author(s): Newton David W
May/Jun 2009
Pg. 234-238
Jul/Aug 2008
Pg. 344-353
Jul/Aug 2004
Pg. 251-263
Nov/Dec 2007
Pg. 492-499
Jul/Aug 2009
Pg. 322-329
Nov/Dec 2009
Pg. 546-553
Mar/Apr 2012
Pg. 146-150
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 6-10
Author(s): McElhiney Linda F
Nov/Dec 2011
Pg. 488-496
Author(s): Allen Loyd V Jr